JohnMSharrettsMD

Endocrinology • Philadelphia, PA

Diabetes, Lipid Metabolism

Assistant Professor, Medicine, Perelman School of Medicine

Join to view full profile

Dr. Sharretts is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sharretts' full profile

Already have an account?

Office
3400 Civic Center Boulevard
West Pavilion, 4th Floor
Philadelphia, PA 19104
Phone+1 215-662-2300

Education & Training

National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2008 - 2011
MedStar Health/Georgetown-Washington Hospital CenterResidency, Internal Medicine, 1995 - 1999
Greater Baltimore Medical CenterInternship, Transitional Year, 1994 - 1995
Virginia Commonwealth University School of MedicineClass of 1994

Certifications & Licensure

DC State Medical License 1997 - 2024
MD State Medical License 1999 - 2015
PA State Medical License 2011 - 2014
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Publications & Presentations

PubMed

4 citations
Should responder analyses be conducted on continuous outcomes?
Robert Abugov, Jennifer Clark, Laura Higginbotham, Feng Li, Lei Nie
Pharmaceutical Statistics. 2023-03-01
71 citations
Cancer Risk Associated with Lorcaserin — The FDA’s Review of the CAMELLIA-TIMI 61 Trial
John Sharretts, Ovidiu Galescu, Shanti Gomatam, Eugenio Andraca-Carrera, Christian Hampp
The New England Journal of Medicine. 2020-09-09
7 citations
Clinical presentation and management of primary ovarian neuroendocrine tumor in multiple endocrine neoplasia type 1.
Sakshi Jhawar, Rahul Lakhotia, Mari Suzuki, James Welch, Sunita K. Agarwal
Endocrinology, Diabetes & Metabolism Case Reports. 2019-08-20

Press Mentions

Novo’s Semaglutide Scores in Liver Fibrosis and MASH TrialNovember 4th, 2024
FDA Approves Tirzepatide for Treating ObesityNovember 9th, 2023
Wegovy vs. Ozempic: The Truth About These New Weight-Loss DrugsApril 6th, 2023
Join now to see all